Journal of Pediatric and Adolescent Gynecology
Volume 23, Issue 5 , Pages 285-289 , October 2010

Characteristics of Polycystic Ovarian Syndrome and Relationship with Ghrelin in Adolescents

  • I.T. Ozgen, MD

      Affiliations

    • Department of Pediatrics, Division of Pediatric Endocrinology, Ondokuz Mayis University Medical Faculty, Samsun, Turkey
    • Corresponding Author InformationAddress correspondence to: Ilker Tolga Ozgen, MD, Bakirkoy Maternity and Children Diseases Training and Research Hospital, Yenimahalle, Bakirkoy, Istanbul, Turkiye
    • ,
  • M. Aydin, MD

      Affiliations

    • Department of Pediatrics, Division of Pediatric Endocrinology, Ondokuz Mayis University Medical Faculty, Samsun, Turkey
    • ,
  • A. Guven, MD

      Affiliations

    • Department of Pediatrics, Division of Pediatric Endocrinology, Ondokuz Mayis University Medical Faculty, Samsun, Turkey
    • ,
  • Y. Aliyazıcıoglu, MD

      Affiliations

    • Department of Clinical Biochemistry, Ondokuz Mayis University Medical Faculty, Samsun, Turkey

References 

  1. Sheehan MT. Polycystic ovarian syndrome: diagnosis and management. Clin Med Res. 2004;2:13
  2. Ten S, Maclaren N. Insulin resistance syndrome in children. J Clin Endocrinol Metab. 2004;89:2526
  3. Barnes RB, Rosenfield RL, Burstein S, et al. Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome. N Engl J Med. 1989;320:559
  4. Yen SS, Vela P, Rankin J. Inappropriate secretion of follicle stimulating hormone and luteinizing hormone in polycystic ovarian disease. J Clin Endocrinol Metab. 1970;30:435
  5. Dunaif A. Insulin resistance and polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev. 1996;18:774
  6. Pagotto U, Gambineri A, Vicennati V, et al. Plasma ghrelin, obesity, and the polycystic ovary syndrome: correlation with insulin resistance and androgen levels. J Clin Endocrinol Metab. 2002;87:5625
  7. Gaytan F, Barreiro ML, Chopin LK, et al. Immunolocalization of ghrelin and its functional receptor, the type 1a growth hormone secretagogue receptor, in the cyclic human ovary. J Clin Endocrinol Metab. 2003;88:879
  8. Muccioli G, Tschöp M, Papotti M, et al. Neuroendocrine and peripheral activities of ghrelin: implications in metabolism and obesity. Eur J Pharmacol. 2002;440:235
  9. Miller DW, Harrison JL, Brown YA, et al. Immunohistochemical evidence for an endocrine/paracrine role for ghrelin in the reproductive tissues of sheep. Reprod Biol Endocrinol. 2005;3:60
  10. Fernández-Fernández R, Tena-Sempere M, Navarro VM, et al. Effects of ghrelin upon gonadotropin-releasing hormone and gonadotropin secretion in adult female rats: in vivo and in vitro studies. Neuroendocrinology. 2006;82:245
  11. Sultan C, Paris F. Clinical expression of polycystic ovary syndrome in adolescent girls Fertil Steril. 2006;86(Suppl 1):S6
  12. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, et al. CDC growth charts: United States. Adv Data. 2000;314:1
  13. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412
  14. Valerio G, Licenziati MR, Iannuzzi A, et al. Insulin resistance and impaired glucose tolerance in obese children and adolescents from Southern Italy. Nutr Metab Cardiovasc Dis. 2006;16:279
  15. Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab. 1961;21:1440
  16. Nardo LG, Buckett WM, Khullar V. Determination of the best-fitting ultrasound formulaic method for ovarian volume measurement in women with polycystic ovary syndrome. Fertil Steril. 2003;79:632
  17. Diamanti-Kandarakis E. PCOS in adolescents. Best Pract Res Clin Obstet Gynaecol. 2010;24:173
  18. Buyalos RP, Geffner ME, Watanabe RM, et al. The influence of luteinizing hormone and insulin on sex steroids and sex hormone-binding globulin in the polycystic ovarian syndrome. Fertil Steril. 1993;60:626
  19. Cara JF, Mirmira RG, Nakagawa SH, et al. An insulin-like growth factor I/insulin hybrid exhibiting high potency for interaction with the type I insulin-like growth factor and insulin receptors of placental plasma membranes. J Biol Chem. 1990;265:17820
  20. Berker B, Emral R, Demirel C, et al. Increased insulin-like growth factor-I levels in women with polycystic ovary syndrome, and beneficial effects of metformin therapy. Gynecol Endocrinol. 2004;19:125
  21. Nestler JE. Insulin regulation of human ovarian androgens. Hum Reprod. 1997;12(Suppl 1):53
  22. Zhang G, Veldhuis JD. Insulin drives transcriptional activity of the CYP17 gene in primary cultures of swine theca cells. Biol Reprod. 2004;70:1600
  23. Fendri S, Arlot S, Marcelli JM, et al. Relationship between insulin sensitivity and circulating sex hormone-binding globulin levels in hyperandrogenic obese women. Int J Obes Relat Metab Disord. 1994;18:755
  24. Dunaif A. Insulin resistance in women with polycystic ovary syndrome. Fertil Steril. 2006;86(Suppl 1):S13
  25. Dunaif A, Segal KR, Futterweit W, et al. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes. 1989;38:1165
  26. Chang RJ, Nakamura RM, Judd HL, et al. Insulin resistance in nonobese patients with polycystic ovarian disease. J Clin Endocrinol Metab. 1983;57:356
  27. Dale PO, Tanbo T, Vaaler S, et al. Body weight, hyperinsulinemia, and gonadotropin levels in the polycystic ovarian syndrome: evidence of two distinct populations. Fertil Steril. 1992;58:487
  28. Herbert CM, Hill GA, Diamond MP. The use of the intravenous glucose tolerance test to evaluate nonobese hyperandrogenemic women. Fertil Steril. 1990;53:647
  29. Bhattacharya SM, Ghosh M. Insulin resistance and adolescent girls with polycystic ovary syndrome. J Pediatr Adolesc Gynecol. 2010;23:158
  30. Schofl C, Horn R, Schill T, et al. Circulating ghrelin levels in patients with polycystic ovary syndrome. J Clin Endocrinol Metab. 2002;87:4607
  31. Panidis D, Farmakiotis D, Koliakos G, et al. Comparative study of plasma ghrelin levels in women with polycystic ovary syndrome, in hyperandrogenic women and in normal controls. Hum Reprod. 2005;20:2127
  32. Bideci A, Camurdan MO, Yeşilkaya E, et al. Serum ghrelin, leptin and resistin levels in adolescent girls with polycystic ovary syndrome. J Obstet Gynaecol Res. 2008;34:578
  33. Moran LJ, Noakes M, Clifton PM, et al. Ghrelin and measures of satiety are altered in polycystic ovary syndrome but not differentially affected by diet composition. J Clin Endocrinol Metab. 2004;89:3337
  34. Barber TM, Casanueva FF, Karpe F, et al. Ghrelin levels are suppressed and show a blunted response to oral glucose in women with polycystic ovary syndrome. Eur J Endocrinol. 2008;158:511

PII: S1083-3188(10)00111-7

doi: 10.1016/j.jpag.2010.02.011

Journal of Pediatric and Adolescent Gynecology
Volume 23, Issue 5 , Pages 285-289 , October 2010

Article Tools